Can a higher dose of aspirin prevent a dangerous pregnancy complication?
NCT ID NCT07373756
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a higher dose of aspirin (150mg) is better than the usual dose (75mg) at preventing preeclampsia, a serious condition involving high blood pressure during pregnancy. The trial will include 86 pregnant women in Kathmandu who are at high risk based on a scoring system. Participants will take aspirin daily from enrollment until delivery, and doctors will monitor for signs of preeclampsia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Aspirin
- What this could lead to
- If successful, this could show that a higher dose of aspirin (150mg) is more effective than the standard 75mg at preventing preeclampsia in high-risk pregnancies.
- What could go wrong
- This is a small, single-center trial (86 participants) that hasn't started recruiting yet. Results may not apply to all populations, and aspirin carries risks like bleeding or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY INDUCED HYPERTENSION (PIH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.